ADMA director buys 12,500 shares at $8.01
ADMA Biologics director Jerrold B. Grossman bought 12,500 shares of common stock in an open-market transaction at $8.01 per share.
Rhea-AI Filing Summary
ADMA Biologics director Jerrold B. Grossman bought 12,500 shares of common stock in an open-market transaction at $8.01 per share. Following this purchase, his directly owned stake shown in the filing increased to 501,384 shares of ADMA common stock.
The filing also lists additional ADMA shares held indirectly through Brookwood LLC, the Jerrold Grossman 2019 Irrevocable Trust, Genesis Foundation Inc., and his wife, reflecting interests associated with the director beyond his direct holdings.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 12,500 shares
Net Buy
5 txns
Insider
Grossman Jerrold B
Role
Director
Bought
12,500 shs ($100K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 12,500 | $8.01 | $100K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 501,384 shares (Direct);
Common Stock — 92,707 shares (Indirect, See footnote)
Footnotes (6)
- F1. Represents an open market purchase in a single transaction.
- F2. Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 490,694 shares of common stock owned by the reporting person.
- F3. These shares are owned by Brookwood LLC ("Brookwood"). The Reporting Person is the managing member of Brookwood.
- F4. These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
- F5. These shares are owned by Genesis Foundation Inc. ("Genesis"). The Reporting Person is the President of Genesis.
- F6. These shares are owned by the Reporting Person's wife.
Key Figures
Shares purchased: 12,500 shares
Purchase price: $8.01 per share
Direct holdings after trade: 501,384 shares
+5 more
8 metrics
Shares purchased
12,500 shares
Open-market buy of ADMA common stock
Purchase price
$8.01 per share
Price for the 12,500-share transaction
Direct holdings after trade
501,384 shares
Common stock directly owned after purchase
RSUs granted
10,690 RSUs
Granted February 9, 2026, vesting February 9, 2027
Brookwood LLC holdings
175 shares
Common stock owned by Brookwood LLC
Irrevocable Trust holdings
38,294 shares
Common stock held by 2019 Irrevocable Trust
Genesis Foundation holdings
31,381 shares
Common stock owned by Genesis Foundation Inc.
Spouse holdings
22,857 shares
Common stock owned by reporting person’s wife
Key Terms
open market purchase, RSUs, Irrevocable Trust, Brookwood LLC, +2 more
6 terms
open market purchase financial
"Represents an open market purchase in a single transaction."
An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.
RSUs financial
"Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest..."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Irrevocable Trust financial
"These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee."
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
Brookwood LLC financial
"These shares are owned by Brookwood LLC ("Brookwood"). The Reporting Person is the managing member of Brookwood."
Genesis Foundation Inc. financial
"These shares are owned by Genesis Foundation Inc. ("Genesis"). The Reporting Person is the President of Genesis."
indirect ownership financial
"Common Stock entries with ownership_type "indirect" and nature_of_ownership "See footnote"."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ADMA (ADMA) director Jerrold Grossman report?
Director Jerrold B. Grossman reported an open-market purchase of 12,500 shares of ADMA Biologics common stock. The shares were bought at $8.01 per share, increasing his directly held position as reflected in this Form 4 filing.
What equity awards are included in Jerrold Grossman’s ADMA (ADMA) holdings?
His holdings include 10,690 restricted stock units (RSUs) granted on February 9, 2026. These RSUs will fully vest on February 9, 2027, provided he continues his service through that vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
